Pemphigus Vulgaris
Dermatology·MeSH: Pemphigus
Prevalence
5.0 / 100K
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| rese-cel | Cabaletta Bio, Inc. (CABA) |
Phase 1(1)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| DSG3-CAART | Cabaletta Bio, Inc. (CABA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Pemphigus Vulgaris?
BioSniper tracks 3 drugs in development for Pemphigus Vulgaris across 1 company.
How many clinical trials target Pemphigus Vulgaris?
There are 1 clinical trial targeting Pemphigus Vulgaris tracked by BioSniper.
What is the prevalence of Pemphigus Vulgaris?
The estimated prevalence of Pemphigus Vulgaris is approximately 5.0 per 100,000 population.
Deep-dive into Pemphigus Vulgaris
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis